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Abstract: The present study evaluated the antiulcerogenic activity and mechanisms of  
the aqueous (AqF 100 mg/kg) and ethyl acetate (AcF 50 mg/kg) fractions from  
Indigofera truxillensis leaves. This dose was selected to assess its activity on ulcer healing 
and its action on gastric acid and mucus secretion, prostaglandin production and 
antioxidant enzyme activity (superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) 
and glutathione reductase (GSH-Rd)). Gastric ulcer was induced by absolute ethanol. 
Antisecretory action, mucus and prostaglandin production, healing and antioxidant enzyme 
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activities were evaluated for both fractions. AqF and AcF significantly inhibited the gastric 
mucosal damage caused by ethanol. This effect was statistically significant at 100 and  
50 mg/kg compared with the vehicle. Neither fraction interfered with gastric secretion. AcF 
increased the PGE2 production, and both fractions increased mucus production. L-NAME 
did not alter the gastroprotection exerted by the fractions, but N-ethylmaleimide attenuated 
only AcF. In the ischemia/reperfusion model both fractions inhibited the mucosal damage. 
AcF increased SOD, GSH-Px and GSH-Rd activity, but AqF increased only SOD and 
GSH-Px. In the acetic acid-induced ulcer model AcF only accelerated ulcer healing. These 
results showed that Indigofera truxillensis acted as a gastroprotective agent, stimulating 
protective factors and antioxidants enzymes.  
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1. Introduction 
The genus Indigofera, one of the six largest genera of the Leguminosae, contains approximately 
700 herbaceous and bushy species and occurs in the state of São Paulo and in north and northeastern 
Brazil [1]. Indigofera truxillensis is typical of the ‘cerrado’, Brazilian’s savannah like region, known 
by the popular name of ‘anileira’. Furthermore, the aerial parts of I. truxillensis are used in folk medicine 
for the treatment of gastric pain and disorders [2,3]. Apart these medicinal uses, pharmacological 
studies showed antimycobacterial and antiulcerogenic activities of another species of the same Genus, 
I. suffruticosa [4,5]. 
Phytochemical studies carried out with I. truxillensis revealed an abundant amount of several 
compounds, including kaempferol 3-O-α-l-rhamnopyranoside and kaempferol 7-O-α-l-rhamnopyranoside, 
kaempferol 3-O-α-l-rhamnopyranoside-7-O-α-1-rhamnopyranoside and kaempferol 3-O-α-l-
arabinopyranoside-7-O-α-l-rhamnopyranoside, as well as the alkaloids indigo and indirubin [6]. 
Recently, we have demonstrated that the alkaloid indigo from I. truxillensis modulates antioxidant 
enzymes in the rat and markedly inhibits gastric mucosal lesions induced by ethanol 70% [7]. 
The present work was carried out to investigate the possible antiulcerogenic effect of the ethyl 
acetate (AcF) and aqueous (AqF) fractions from the leaves of I. truxillensis on acute and subacute 
experimental models of gastric ulcers in rodents. In addition, antioxidant enzymes (superoxide 
dismutase (SOD), glutathione peroxidase (GSH-Px) and glutathione reductase (GSH-Rd)), mucus 
secretion, prostaglandin production and acid secretion were evaluated as possible mechanisms of 
action of the fractions.  
2. Results and Discussion 
2.1. Analyses of Secondary Metabolites 
The analyses of the aqueous fraction (AqF) showed the presence of flavonoids (52%), glycerolipids 
(43%) and alkaloids (5%), while the ethyl acetate fraction (AcF) contained flavonoids (28%), 
glycerolipids (48%) and alkaloids (24%). 
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2.2. Ethanol-Induced Gastric Lesions 
The oral doses (50, 100 and 200 mg/kg) were initially used to establish a general profile of the 
antiulcerogenic activity of both AqF and AcF (Table 1). Both fractions protected the mucosa against 
the damage caused by ethanol at all the tested doses. However, the AcF fraction presented the same 
profile of gastroprotection at all the doses tested (50, 100 and 200 mg/kg), but with no significant 
statistical difference between them. Therefore, in the other assays, we used the lowest effective dose  
(50 mg/kg). In the AqF fraction, the lowest effective dose was 100 mg/kg, which determined its 
subsequent use.  
Table 1. Effects of lansoprazole (30 mg/kg), aqueous fraction (AqF) and ethyl acetate 
(AcF) from Indigofera truxillensis (50, 100 and 200 mg/kg) on ethanol-induced gastric 
mucosal ulcers in rats. The results are reported as the mean ± SD. ANOVA followed by  
Dunnett’s test.  
Treatments (p.o.) N Dose (mg/kg) Ulcer index Inhibition (%) 
Saline 5 10 mL/kg 66.4 ± 15.4 - 
Lanzoprazole 5 30 19.8 ± 6.4 ** 70 
AqF–I. truxillensis 5 50 43.4 ± 14.6 * 35 
AqF–I. truxillensis 5 100 13.8 ± 6.3 ** 79 
AqF–I. truxillensis 5 200 25.4 ± 9.0 ** 61 
12% Tween 5 10 mL/kg 33.8 ± 13.1 - 
Lansoprazole 5 30 1 ± 0.7 ** 97 
AcF–I. truxillensis 5 50 6.4 ± 2.7 ** 81 
AcF–I. truxillensis 5 100 6.2 ± 4.0 ** 81 
AcF–I. truxillensis 5 200 6.0 ± 2.5 ** 82 
* p < 0.05, ** p < 0.01 compared to the corresponding vehicle group. 
A complex series of morphological and functional changes occurs in gastric tissues after exposure 
to various ulcerogenic agents. The administration of absolute ethanol produces numerous gastric 
mucosal lesions, a decrease in gastric blood flow, generation of reactive oxygen species and an 
increase in inflammatory mediators, including IL-1β and TNF-α [8]. 
The balance between the therapeutic and the toxicological effects of a drug is an important 
parameter when assessing its applicability regarding the pharmacological action [9]. Cola-Miranda  
et al. [3] showed that the groups treated with Indigofera truxillensis did not show significant 
differences in body weight development or in organ weight between the groups studied. In addition, no 
macroscopic abnormalities or mortality was observed during the 14-day study. In addition, we 
evaluated the cytotoxicity of the fractions (2, 4, 6, 8 and 10 mg/mL) used in this work in V79 cells by 
the neutral red assay, which showed no toxicity (data not shown). 
Indigofera truxillensis has been documented to contain the alkaloid indigo as its main  
compound [6]. Farias-Silva et al. [7] showed that indigo partially protects the gastric mucosa against  
ethanol-induced DNA damage. Since the AcF from Indigofera truxillensis has been found to contain 
indigo as its constituent, the mucosal protection against ethanol of the AcF (50, 100 or 200 mg/kg) was 
evaluated. AcF fractions protected the gastric mucosa at the three doses tested without any statistically 
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significant difference between them. Thus, the remaining tests were conducted with the most effective 
dose for AqF (100 mg/kg) and the lowest effective dose for AcF (50 mg/kg). The AqF fraction was 
more effective at 100 mg/kg when compared with doses of 50 and 200 mg/kg. The AqF fraction 
presents 52% flavonoids in its composition, which partially explains its behavior in this model. Low 
concentrations of the flavonoid present antioxidant activity whereas higher concentrations of the flavonoid 
decrease this activity [10]. Our results are in accordance with those obtained by Cola-Miranda et al. [3] 
who evaluated the antiulcerogenic action of the methanolic extract from I. truxillensis.  
2.3. Gastric Secretion in Lesions Induced by Pylorus Ligature 
To evaluate the biochemical parameters from the gastric content, rats were subjected to pylorus 
ligature and treatment with AqF and AcF from I. truxillensis. The results obtained did not change the 
pH. However, the animals treated with AcF (50 mg/kg) showed a diminished gastric volume (Table 2). 
Table 2. Effects of intraduodenal adminstration of cimetidine (100 mg/kg) AqF  
(100 mg/kg) and AcF (50 mg/kg) from Indigofera truxillensis on the biochemical 
parameters of gastric juice in pylorus-ligated rats. The results are the mean ± SD of five 
rats per group. ANOVA followed by Dunnett’s test.  
Treatments (i.d.) N Dose (mg/kg) pH units Gastric juice (mg) 
Saline 5 10 mL/kg 2.7 ± 0.2 0.5 ± 0.1 
Cimetidine 5 100 3.2 ± 0.1 ** 0.5 ± 0.0 
AqF–I. truxillensis 5 100 2.8 ± 0.1 0.5 ± 0.1 
12% Tween 5 10 mL/kg 3.2 ± 0.1 0.6 ± 0.1 
Cimetidine 5 100 3.7 ± 0.2 ** 0.5 ± 0.1 
AcF–I. truxillensis 5 50 3.3 ± 0.2 0.4 ± 0.1 * 
* p < 0.05, ** p < 0.01 compared to the corresponding vehicle group. 
Gastric acid secretion is a phylogenetically old function that developed about 500 million years  
ago [11]. It is regulated by biological agents, produced and released by enteroendocrine cells and 
neurons, as well as by exogenously administered substances and infections. When gastric secretion is 
excessive, it can lead to peptic ulcer disease [12]. However, excessive acid secretion is not, in many 
cases, the main player in the genesis of peptic ulcer [13]. Corroborating with Cola-Miranda et al. [3] in 
the pylorus ligature model, both fractions were not capable of inhibiting the acid secretion. It is also 
necessary to consider that the decrease in acid secretion can interfere with the absorption of certain 
nutrients and medications and may also lead to a predisposition to enteric infection [14]. 
2.4. Prostaglandin Production Determination 
Figure 1A shows that AqF (100 mg/kg) was not able to maintain the levels of PGE2. On the other 
hand, AcF (50 mg/kg) increased and maintained a high PGE2 level despite the administration of 
indomethacin (Figure 1B). AcF was able to promote a sustained increase in PGE2 levels, which is vital 
to the integrity of the gastric mucosa. Furthermore, the combination of AcF and NSAID was not 
capable of reducing the levels of PGE2 release in a significant manner. 
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Figure 1. Effect of orally administered (A) AqF (100 mg/kg) and (B) AcF (50 mg/kg) from 
Indigofera truxillensis and indomethacin on gastric prostaglandin E2 (PGE2) production in 
rats. The results are reported as the mean ± SD. ANOVA followed by Tukey’s test.  
p < 0.01 compared to the corresponding vehicle group. 
 
 
The gastric mucosa is continuously exposed to noxious substances and has specific defense 
mechanisms for maintaining its structural integrity [15]. The epithelial surface secretes a barrier 
consisting of water, mucin bicarbonate and prostaglandins [15]. 
Prostaglandins, particularly PGE2, play an important role in modulating the mucosal integrity by  
the regulation of gastro-duodenal bicarbonate secretion [15,16]. We observed that AqF (100 mg/kg) 
treatment was unable to increase PGE2 levels in the gastric mucosa when compared to the sham group. 
Phenol compounds such as flavonoids have a dual effect on prostaglandin biosynthesis; low 
concentrations stimulate and high concentrations inhibit it [17]. Probably, the dose used may inhibit 
PGE2 secretion, exerting its gastroprotective action through a distinct mechanism. AcF (50 mg/kg)  
was able to increase PGE2 levels when compared to the sham group, these levels were kept even in  
the presence of indomethacin. Toma et al. [18] showed that alkaloids are capable of increasing 
prostaglandin and mucus production. Prostaglandin stimulates mucus secretion and also protects the 
gastric mucosa against noxious agents such as ethanol and indomethacin [16]. 
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2.5. Determination of the Gastric Mucus Content 
Still looking for a possible mechanism for the increase in gastric mucosa protective factors, we 
investigated the effects of AcF (50 mg/kg) and AqF (100 mg/kg) on mucus production. Pretreatment 
with both fractions and carbenoxolone (200 mg/kg) significantly increased the amount of adherent 
mucus in the gastric mucosa when compared to the control group (Figure 2A,B). 
Figure 2. Effects of oral carbenoxolone (200 mg/kg), (A) AqF (100 mg/kg) or (B) AcF  
(50 mg/kg) obtained from Indigofera truxillensis on the production of adherent gastric 
mucus (measured as the amount of bound alcian blue) in pylorus-ligated rats. The results 



























































The mucus secretion, another defense mechanism for the maintenance of the gastric mucosa,  
covers the gastrointestinal tract, including the stomach, protecting the mucosa against damage [19]. 
Pretreatment with carbenoxolone (200 mg/kg), AqF (100 mg/kg) or AcF (50 mg/kg) significantly 
increased the amount of adherent mucus in the gastric mucosa when compared to the control group.  
A range of environmental stimuli can alter the rate of mucin release, including prostaglandin [16] and 
nitric oxide (NO) [20]. Considering that AqF (100 mg/kg) was unable to increase prostanglandin 
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production, this increase in mucus can be a result of NO. In fact, the expression of mucins by mucosal 
epithelial cells in vitro can be directly upregulated by NO [21]. On the other hand, the increase 
promoted by AcF (50 mg/kg) can be attributed to a PGE2 increase promoted by the fraction. This 
gastric mucus increase is one of the antiulcerogenic mechanisms involved with the antiulcer effects of 
this fraction. 
2.6. Determination of the Role of Nitric Oxide (NO) and Sulfhydryl Compounds (SH) in  
Gastric Protection 
Figure 3 shows that both fractions, AqF (100 mg/kg) and AcF (50 mg/kg), protected the gastric 
mucosa against ethanol-induced gastric ulcers, even in the L-NAME-challenged animals. When  
N-ethylmaleimide (NEM), an SH blocker, was administered, only the AcF (50 mg/kg) gastroprotection 
was attenuated (Figure 4A,B). 
Figure 3. The ulcer index for gastric ulcers induced by ethanol in rats pretreated with  
L-NAME (70 mg/kg) alone or together with carbenoxolone (100 mg/kg), (A) AqF  
(100 mg/kg) or (B) AcF (50 mg/kg) of Indigofera truxillensis. The results are reported as 
the mean ± SD. ANOVA followed by Tukey’s test. p < 0.05 compared to the 
corresponding vehicle group. 
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Figure 4. The ulcer index for gastric ulcers induced by ethanol in rats pretreated with  
N-ethylmaleimide (NEM) (10 mg/kg) alone or together with carbenoxolone (100 mg/kg)  
(A) AqF (100 mg/kg) or (B) AcF (50 mg/kg) of Indigofera truxillensis. The results are 
reported as the mean ± S.D. ANOVA followed by Tukey’s test. p < 0.05 compared to the 
corresponding vehicle group. 
 
 
Recent research has also highlighted the fact that the protective functions of prostaglandins in the 
stomach can be exerted by other mediators, in particular NO [22]. The release of NO causes 
vasodilatation of submucosal arterioles increasing the mucosal blood flow. This increase in blood flow 
allows the buffering of acid that has entered the lamina propria and helps to dilute and remove any 
toxins that have crossed the epithelium [23]. 
Aiming at evaluating the participation of endogenous nitric oxide (NO) in the gastroprotection of 
AqF and AcF, we used L-NAME, an NO synthase inhibitor. Our results did not show any increase in 
the gastric lesions after blocking nitric oxide production with L-NAME, suggesting that the 
gastroprotective effect of both fractions was not mediated by the nitric oxide pathway. 
Non-protein sulfhydryl (SH) compounds limit the production of oxygen-derived free radicals and 
are involved in cellular protection [24]. In experimental animals, ethanol-induced damage to the gastric 
mucosa was associated with a significant decrease in the levels of SH-compounds, especially 
glutathione [25]. SH-compounds have been implicated in the maintenance of gastric integrity, 
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particularly when reactive oxygen species are involved in the pathophysiology of tissue damage [26]. 
Figure 4 shows that NEM, an SH blocker, significantly attenuates the gastroprotective effect of AcF 
(50 mg/kg), which indicates that part of the protective action is mediated by endogenous SHs. 
2.7. Gastric Ischemia–Reperfusion 
The ischemia achieved in the different experimental groups by occlusion of the celiac artery for  
30 min, followed by 60 min of reperfusion, produced ulcerative lesions in the gastric mucosa of  
the rats. Table 3 shows a significant reduction of lesions in the animals pretreated with rutin  
(200 mg/kg) and both fractions AqF (100 mg/kg) and AcF (50 mg/kg) from I. truxillensis compared 
with the respective controls.  
Table 3. Effect of orally administered AqF (100 mg/kg) and AcF (50 mg/kg) from  
Indigofera truxillensis on ulcers produced by ischemia-reperfusion in rats. The results are 
reported as the mean ± SD. ANOVA followed by Tukey’s test. ** p < 0.01 compared to 
the corresponding vehicle group. 
Treatment (p.o) N Dose (mg/kg) Ulcer area (mm2) Inhibition (%) 
Sham 5 - 0 ± 0 ** - 
Saline 5 10 mL/kg 1.7 ± 0.8 - 
Rutin 5 200 0.3 ± 0.1 ** 82 
AqF–I. truxillensis 5 100 0.3 ± 0.1 ** 82 
12% Tween 5 10 mL/kg 15.6 ± 5.3 - 
Rutin 5 200 5.3 ± 3.2 ** 66 
AcF–I. truxillensis 5 50 0.8 ± 0.1 ** 95 
Ischemia and reperfusion (IR) are known to induce gastric lesions, predominantly due to the 
excessive formation of reactive oxygen metabolites that induce inflammatory responses and tissue 
damage by fragmenting cellular DNA [15]. Ischemia weakens the gastric mucosal barrier and 
increases the acid back-diffusion predisposing the gastric mucosa to damage [27]. After reperfusion, 
reactive oxygen species (ROS) are generated from the xanthine-xanthine oxidase system and activate 
neutrophils, leading to tissue lipid peroxidation, which in combination with gastric secretion results in 
damage and cellular death [28]. 
ROS are involved in the ethanol-induced mucosal damage leading to oxidative stress. In order  
to protect tissues against the damage provoked by ROS, the cells contain antioxidant enzymes, 
including superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and glutathione reductase 
(GSH-Rd) [7].  
The gastric lesions were reduced by both AqF and AcF fractions by 82% and 95%, respectively, 
when compared to the respective control groups. This protection may be due to flavonoid presence in 
the species challenged. These compounds present antioxidant activity, inhibiting the formation of free 
radicals [29]. Considering these results, we evaluated which enzymes (SOD, GSH-Px and GSH-Rd) 
were involved in the antioxidant activity. 
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2.8. Glutathione Peroxidase (GSH-Px), Glutathione Reductase (GSH-Gr) and Superoxide Dismutase 
(SOD) Activities 
In the antioxidant assays we evaluated the enzyme activities of GSH-Px, GSH-Rd and SOD in the 
ischemia/reperfusion-induced ulcer model. Table 4 shows that pretreatment with AqF (100 mg/kg) 
significantly increases the SOD and GSH-Rd activities, but does not alter the GSH-Px activity.  
AcF (50 mg/kg) promotes an increase in GSH-Px, GSH-Rd and SOD activities. 
Table 4. Effect of AqF (100 mg/kg) and AcF (50 mg/kg) on antioxidant enzymes activity 
in the gastric mucosa of rats submitted to ischemia-reperfusion. The results are reported as 
the mean ± SD. ANOVA followed by Dunnett’s test. ** p < 0.01 compared to the 













Sham - 10.6 ± 1.9 36.9 ± 8.7 27.6 ± 2.8 
Saline 10 mL/kg 3.7 ± 0.5 23.8 ± 1.5 12.8 ± 0.1 
Rutin 200 19.0 ± 4.3 ** 19.2 ± 4.0 19.3 ± 3.2 
AqF–I. truxillensis 100 8.8 ± 0.9 * 26.5 ± 3.9 109.2 ± 28.0 ** 
12% Tween 10 mL/kg 3.8 ± 0.7 13.9 ± 0.9 8.6 ± 0.5 
Rutin 200 7.8 ± 1.5 16.2 ± 1.6 15.2 ± 2.4 
AcF–I. truxillensis 50  8.9 ± 1.9 * 33.7 ± 5.6 * 22.4 ± 3.5 * 
The antioxidant enzyme SOD plays an important role in the protection against oxidative stress [30]. 
This enzyme is the first gastric mucosa antioxidant enzyme, which catalyzes the dismutation of O2
● 
into H2O2, which is less harmful [8]. The GSH-Px is fundamental to the elimination of hydrogen 
peroxide and lipid hydroperoxides in the gastric mucosa cells [31]. The antioxidant activity of GSH-Px 
is coupled with the oxidation of reduced glutathione (GSH), which can subsequently be reduced by  
GSH-Rd using NADPH as the reducing agent [8]. We observed that pre-treatment with AqF  
(100 mg/kg) significantly increased the activity of SOD and GSH-Rd. AcF (50 mg/kg) promoted a 
significant increase in the activity of SOD, GSH-Px and GSH-Rd. ROS participate in the etiology and 
pathophysiology of gastric ulcers [32]. Drugs with multiple mechanisms of protective action, such as 
antioxidant properties, may be one way forward towards minimizing tissue injury in human  
disease [33]. Medicinal plants present many compounds that may modulate the levels of various 
endogenous antioxidant enzymes [34] and thus can be a useful strategy in the gastric ulcer treatment.  
2.9. Healing in Acetic-Induced Gastric Lesions 
In the acetic acid-induced gastric ulcer model, the 14-consecutive day treatment with cimetidine 
(100 mg/kg) and AcF from I. truxillensis reduced the ulcer area by 68% and 38%, respectively. On the 
other hand, the AqF (100 mg/kg) fraction was not able to reduce the ulcers induced by acetic-acid 
(Table 5).  
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Table 5. Effect of orally administered AqF (100 mg/kg) and AcF (50 mg/kg) from  
Indigofera truxillensis on healing of ulcers produced by the injection of a 30% acetic acid 
solution into the stomachs of rats. The ulceration was scored on the 15th day after surgery. 
The results are reported as the mean ± SD. ANOVA followed by Dunnett’s test. * p <0.05,  
** p < 0.01 compared to the corresponding vehicle group. 
Treatment N Dose (mg/kg) Ulcer area (mm2) Cure rate (%) 
Sham 5 - 0 ± 0 ** - 
Saline 5 10 mL/kg 3.9 ± 0.9 - 
Cimetidine 5 100 1.6 ± 0.6 ** 57 
AqF–I. truxillensis 5 100 3.6 ± 0.8 - 
12% Tween 5 10 mL/kg 4.5 ± 0.4  
Cimetidine 5 100 1.4 ± 0.5 ** 68 
AcF–I. truxillensis 5 50 2.8 ± 1.4 * 38 
The acetic acid ulcer model highly resembles human ulcers in terms of both pathological features 
and healing process [35,36]. 
The ulcer produced by the injection of acetic acid into the stomach wall of the rats is assumed to be 
similar to the human chronic ulcer, since it is difficult to be treated and it takes long to heal. Studies 
have demonstrated that reepithelialized mucosa of grossly “healed” experimental gastric ulcers has 
prominent histologic and ultrastructural abnormalities: reduced height, marked dilation of gastric 
glands, increased connective tissue, a disorganized microvascular network and increased capillary 
permeability [37]. These abnormalities may interfere with mucosal defense and cause ulcer recurrence 
when ulcerogenic factors are present [38]. 
Postoperative treatment with AqF (100 mg/kg) and AcF (50 mg/kg) for 14 consecutive days 
demonstrated that only AcF accelerated ulcer healing. On day 14 after surgery, the percentage of rats 
with cicatrized ulcers in AcF was significantly higher than those of the vehicle group. Ulcer healing is 
a genetically programmed repair process, which is controlled by growth factors such as EGF [38]. 
Alkaloid, a major compound in AcF, increased the EFG expression in gastric mucosa in acetic  
acid-induced gastric lesions [39]. This fact can partially explain the healing enhancement showed by 
AcF. On the other hand, AqF had no significant effect on the ulcerated area. However, we observed a 
thicker regenerative mucosa under treatment with AqF, which denotes greater cell proliferation at that 
site, contributing to the cicatrization of the ulcer [40]. 
The traditional use of Indigofera truxillensis is reported by the pharmacopeia of Cuba, in which  
the aerial parts of this species are used for digestive tract disorders [2]. Cola-Miranda et al. [3] 
confirmed the activity attributed by folk medicine studying the anti-ulcerogenic activity of  
I. truxillensis that pointed to an antissecretory and cytoprotective mechanism. However, the 
gastroprotective action does not ensure a healing activity of the plant in an already installed gastric 
lesion, and this has still not been evaluated. In this context, I. truxillensis was evaluated for its efficacy 
in the ulcer-healing model, which highly resembles human ulcers [35,36] and is effective only with the 
AcF fraction. Furthermore, both fractions protected the gastric mucosa against damage caused by ROS 
and increased the key activity of anti-oxidizing enzymes such as superoxide dismutase in the IR 
model. Thus, this study showed novel healing and antioxidant activities of the species I. truxillensis. 
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3. Experimental Section  
3.1. Animals 
Male Unib: WH rats (180–250 g) obtained from the State University of Campinas 
(CEMIB/UNICAMP) Brazil, were used. The rats were fed a certified Nuvilab CR-diet, with free 
access to tap water and were housed on a 12 h light/dark cycle at 60 ± 1% humidity and 21.5 ± 2 °C. 
The experimental protocols were approved by the institutional Committee for Ethics in Animal 
Experimentation (CEEA/UNICAMP) and were performed in accordance with the Canadian Council 
Guide lines for Animal Care. 
3.2. Drugs 
The following drugs were used: cimetidine, lansoprazole, carbenoxolone, indomethacin, and  
N-ethyl-maleimide (NEM). All drugs and chemicals used were obtained from Sigma Chemical Co.  
(St. Louis, MO, USA) and were prepared immediately before use.  
3.3. Plant Material 
The leaves of I. truxillensis were collected along the Domingos Sartori highway in Rubião Junior, 
Botucatu, São Paulo State, Brazil, in June 2003. The plants were identified by Jorge Tamashiro of the 
Institute of Biology at UNICAMP and a voucher specimen (UEC: 131.827) was deposited in the 
Herbarium at UNICAMP. 
3.4. Preparation of Fractions 
The leaves (1500 g) of I. truxillensis were air dried (seven days at 40 °C), powdered, and then 
exhaustively extracted with chloroform (CHCl3) and methanol (MeOH) successively, at room 
temperature (three chloroform-methanol cycles, with 72 h for each solvent). The solvents were 
evaporated in vacuum to provide a CHCl3 extract (43 g, 3%) and a MeOH extract (110 g, 7.3%).  
A portion (5.0 g) of the MeOH extract was partitioned in ethyl acetate and water (1:1, v/v) to yield  
1.6 g (32%) of the ethyl acetate (AcF) and 2.4 g (48%) of the aqueous fraction (AqF). 
3.5. Identification of Fraction Constituents AcF and AqF  
The AcF and AqF fractions were fractionated in analogous ways by gel permeation 
chromatography. An aliquot of the each fraction (500 mg) was subjected to column chromatography 
on Sephadex LH-20, using methanol as eluent, flowing at 0.5 mL/min. The collected fractions were 
combined into three fractions groups after thin layer chromatography (TLC) analysis. Fraction 1 was 
analyzed by direct injection ESI-IT-MS/MS (electrospray ionization ion trap tandem mass 
spectrometry), which demonstrated that this fraction contained glycerolipids. Fraction 2, denominated 
the flavonoid fraction, was purified by column chromatography and afforded flavonol derivatives of 
kaempferol. Fraction 3, denominated the alkaloid fractions, was chromatographed by Sephadex LH-20 
column and exhibited bis-indole alkaloids. Compounds in Fractions 2 and 3 were identified by MS 
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(mass spectrometry), NMR (nuclear magnetic resonance) techniques and confirmed by comparing the 
physical and spectroscopic/spectrometric data with those in the literature [6]. 
3.6. Antiulcer Activity 
3.6.1. Ethanol-Induced Gastric Lesions 
Ethanol-induced ulcers were produced in rats according to the method of Morimoto et al. [41].  
Rats (n = 5) were randomly separated into ten groups and fasted for 24 h before the experiment. One 
hour after the oral administration of AcF or AqF from I. truxillensis (25, 50, and 100 mg/kg), 
lansoprazole (30 mg/kg), 12% Tween 80 or Saline (10 mL/kg), 1 mL of 99.5% ethanol was given 
orally to the rats. Animals were killed by cervical dislocation 1 h after ethanol administration. Their 
stomachs were removed, opened along the greater curvature, and fixed between two glass plates. The 
inner surface of the stomach was examined with a dissecting microscope (Nikon SMZ800) and the 
number of gastric lesions was counted. The ulcer index was calculated according to the method of 
Szelenyi and Thiemer [42]. 
3.6.2. Gastric Secretion in Lesions Induced by Pylorus Ligature 
The method of Shay et al. [43] was used with some modifications. Rats (n = 5) were fasted for 36 h 
and, immediately after pylorus ligature, AcF (50 mg/kg) and AqF (100 mg/kg) from I. truxillensis, 
cimetidine (100 mg/kg), 12% Tween 80 or Saline (10 mL/kg) was administered intraduodenally. The 
rats were killed 4 h later, and their abdomens were opened and the stomachs removed. The gastric 
juice was collected and weighed (g) and its pH was determined using a pH meter (Quimis Aparelhos 
Científico Ltda, model Q400A, Brazil). 
3.6.3. Prostaglandin Production Determination 
Male rats were divided into nine groups (n = 6). After a 24 h fast, the animals received a 
pretreatment of saline, s.c. (Groups 1, 2, 3 and 4), or indomethacin (dissolved in 5% sodium 
bicarbonate solution) 30 mg/kg, s.c. (Groups 5, 6, 7 and 8). The ninth group consisted of the sham 
control animals. Thirty minutes after pretreatment, saline (Groups 1 and 5), 12% Tween 80 (Groups 2 
and 6), AcF 50 mg/kg (Groups 3 and 7) or AqF 100 mg/kg (Groups 4 and 8) was administered orally. 
Thirty minutes after treatment, all the animals were sacrificed and their abdomens opened. A sample of 
the corpus (full thickness) was excised, weighed and suspended in 1 mL of 1 mM sodium phosphate 
buffer, pH 7.4. The tissue was finely minced with scissors and then incubated at 37 °C for 20 min. 
PGE2 in the buffer was measured by the enzyme immunoassay (R & D systems) and the absorbance was 
read at 450 nm [44]. 
3.6.4. Determination of the Gastric Mucus Content 
This assay was done as described by Rafatullah et al. [45] with some modifications. After a 36 h 
fast, rats (n = 5) received AcF (50 mg/kg) and AqF (100 mg/kg) from I. truxillensis, carbenoxolone 
(200 mg/kg), 12% Tween 80 and Saline (10 mL/kg) orally. Thirty minutes after treatment, the pylorus 
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was ligated. The animals were killed by cervical dislocation 4 h after pylorus ligation and the glandular 
portion of the stomachs was removed and weighed. Each segment was immediately immersed in  
10 mL of 0.1% Alcian blue solution (0.16 M sucrose/0.05 M sodium acetate, pH 5.8) for 2 h, after that 
the excess dye was removed by two successive rinses with 10 mL of 0.25 M sucrose, first for 15 min 
and then for 45 min. Each stomach was then transferred to 0.5 M magnesium chloride solution for 2 h. 
Four milliliters of the dye solution was then vigorously shaken with an equal volume of ether and the 
resulting emulsion was centrifuged at 2000 × g and the absorbance of the aqueous layer was measured 
at 580 nm. The amount of blue dye extracted per gram of wet glandular tissue was then calculated 
from a standard curve of dye prepared in sucrose-acetate solution. 
3.6.5. Determination of the Role of Nitric Oxide (NO) and Sulfhydryl Compounds (SH) in  
Gastric Protection 
Male rats (n = 5) were divided into eight groups and pretreated (i.p.) with saline, L-NAME  
(N-nitro-L-arginine methyl ester 70 mg/kg), an inhibitor of the NO synthesis, or NEM  
(N-ethylmaleimide, 10 mg/kg), a blocker of SH compounds [46]. Thirty minutes after the pretreatment, 
the animals were administered (p.o.) 12% Tween 80 and Saline (10 mL/kg), carbenoxolone  
(100 mg/kg), AcF (50 mg/kg) or AqF (100 mg/kg). After 60 min, all the groups received 1 mL 
absolute ethanol to induce gastric ulcers. One hour after receiving ethanol the rats were killed for the 
determination of gastric lesions. 
3.6.6. Gastric Ischemia–Reperfusion 
Ischemia–reperfusion damage was produced in rats by a method proposed by Ueda et al. [47]. Rats 
(n = 5) received AcF (50 mg/kg) and AqF (100 mg/kg) from I. truxillensis, rutin (200 mg/kg),  
12% Tween 80 and Saline (10 mL/kg) orally. Thirty minutes after, the animals were anaesthetized by 
intramuscular injection of Ketamine (50 mg/Kg)/Xylazine (10 mg/Kg). The left side of the abdomen 
was shaved, and an incision was made. Briefly, the celiac artery was dissected, free of fat excess and 
clamped for 30 min (ischemia phase) using a micro-bulldog clamp. Reoxygenation was allowed by 
removing the clamp for 60 min (reperfusion phase). At the end of this period, the animals were 
sacrificed by cervical dislocation and the stomachs were excised and opened along the great curvature 
for the detection of the ulcer area. A mucosal scrapping was performed right after for the quantification 
of the enzymes (SOD, GSH-Px e GSH-Gr). 
3.7. Enzymatic Assays 
For the enzymatic assays, the stomach of each rat was removed, the mucosa was scrapped off using 
two glass slides on ice, homogenized in phosphate buffer (0.1 M, pH 7.4) and frozen at −80 °C until 
biochemical determination. The changes in absorbance were determined using a Fusion Packard 
spectrophotometer, and the results were expressed as pmol/min/mg protein for GSH-Px and GSH-Gr 
and U/mg protein for SOD activity. The protein concentration of the samples was determined 
following the method described by Bradford [48]. GSH-Px activity was quantified by following the 
decrease in absorbance at 365 nm induced by 0.25 mM H2O2 in the presence of reduced glutathione 
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(10 mM), NADPH, (4 mM), and 1 U enzymatic activity of GSH-Gr [49]. Glutathione reductase 
activity was measured according to Worthington and Rosemeyer [50], following the decrease in 
absorbance at 340 nm induced by oxidized glutathione in the presence of NADPH in phosphate  
buffer, pH 7.8. Absorbance changes were read between 1 and 10 min. SOD activity was analyzed  
by the reduction of nitroblue tetrazolium using a xanthine-xanthine oxidase system, i.e., superoxide 
generation [51]. 
3.8. Healing in Acetic-Induced Gastric Lesion 
The experiment was done according to the method described by Takagi et al. [35] with some 
modifications Okabe and Amagase [36]. Three groups (n = 5) of male Unib: WH rats were fasted for 
24 h before this experiment. Under anesthesia, a laparotomy was done in all animals through a midline 
epigastric incision. After exposing the stomach, 0.05 mL (v/v) of a 30% acetic acid solution was 
injected into the subserosal layer in the glandular part of the anterior wall. The stomach was bathed 
with saline (20 °C) to avoid adherence to the external surface of the ulcerated region. The abdomen 
was then closed and all the animals were fed normally. We selected the lowest effective dose of both 
AcF (50 mg/kg) and AqF (100 mg/kg) fractions of I. truxillensis; cimetidine (100 mg/kg), 12% Tween 
80 and Saline (10 mL/kg), for the determination of the healing effects by the subacute treatment. All 
treatments were done orally once a day during 14 consecutive days beginning one day after surgery. 
One day after the last drug administration, the rats were killed and the stomachs were removed. The 
gastric lesions were evaluated by examining the inner gastric surface with a dissecting magnifying 
glass. The macroscopic ulcer area (mm2) and curative ratio (%) were subsequently determined as 
described by Takagi et al. [35]. 
3.9. Statistical Analysis 
The results were expressed as the mean ± standard deviation. Statistical comparisons were done by 
one-way analysis of variance (ANOVA) followed by the Dunnett’s or Tukey’s post hoc test, with the 
level of significance set at p < 0.05. 
4. Conclusions 
In conclusion, I. truxillensis showed antiulcerogenic activity. Prostaglandin production, mucus 
secretion and antioxidant enzymes are involved in the gastroprotection exerted by this species, 
probably due to the metabolites present in the plant. 
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